Coagulation Bruno Sopko.

Slides:



Advertisements
Similar presentations
Bleeding time is a medical test done on someone to assess their platelet function, count and integrity of the blood vessels.
Advertisements

Chapter 12 Disorders of Hemostasis
Hemostasis, Surgical Bleeding, and Transfusion
Haemostasis Prof. K. Sivapalan.
Pre-analytical factors that can affect coag test results
An Overview of Hemostasis
PLATELETS (PLT) Thrombocytes. PLATELETS (PLT) Thrombocytes.
Basic Principles of Hemostasis
Hemostasis: Dr.Faten Hemostasis: Hemo/Stasis Hemo=BleedigStasis=Stop.
HEMOSTAZ Yard. Doç. Dr. Murat ÖRMEN. Vessels Platelets Fibrinolysis/Inhibitors Coagulation Proteins BleedingClotting Hemostaz.
From Blood to Host Defense Hemostasis and Clotting
HEMOSTASIS. Hemostasis a body mechanism to stop traumatic bleeding to prevent spontaneous bleeding to keep the fluidity of blood.
Hemostasis/Thrombosis I Normal Hemostasis/Thrombosis; Assessment of Clotting System.
Anticoagulation In Dental Procedures Galila Zaher MRCPath KAU Assistant Professor.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
Normal Hemostasis Galila Zaher Consultant Hematologist KAUH.
Biomaterials ResearchBiomaterials Research - Manfred Maitz The Blood Clotting Cascade Manfred Maitz FZ-Rossendorf
Blood coagulation and fibrinolysis Professor Asim K. Duttaroy University of Oslo.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Hemostasis and Blood Coagulation
BLOOD AND BODY DEFENCE Dr. Amel Eassawi Dr. Abdelrahman Mustafa 1.
Associate Professor of Physiology,
HEMOSTASIS Secondary hemostasis.
HAEMOSTASIS AND THROMBOSIS. The integrity of the circulation is maintained by blood flowing through intact vessels lined by endothelial cells. Injury.
Scheme of Coagulation F XIIF XIIa F XIF XIa F IX F X F IXa F VIIaF VII Extrinsic System Tissue damage Release of tissue thromboplastine (F III) Intrinsic.
1 HAEMOSTASIS. 2 Definition Haemostasis is a complex sequence of physical and biochemical changes induced by damage to tissues and blood vessels, which.
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
Hemostasis. Hemostasis Definition Prevention of blood loss (stoppage of blood flow)
Hemostasis Constriction of vessel Aggregation of platelets
Coagulation Mechanisms
Clot Formation Review with Animations
Haemostasis Dr.Salah Elmalik Department of Physiology
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
Investigation of Haemostasis MS. c. program Lab-9.
Examination of hemostasis
Activated Partial Thromboplastin Time (aPTT)
PLATELETS (PLTs) or Thrombocytes Dr. Taj Platelets Thrombocytes are Fragments of megakaryocytes in bone marrow.
Introduction to Haemostasis Ahmad Sh. Silmi Hematologist Msc,FIBMS.
Physiology of Blood. Platelets Small granulated non-nucleated bodies 2-4 micron in diameter Life span….. 8 days Count…300,000/mm 3.
Coagulation and fibrinolysis
Hemodynamics 2.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
بسم الله الرحمن الرحيم.
Chapter 17 Coagulation Testing
Chapter 23. Bleeding disorders associated with coagulopathy
Fibrinolysis, anticaogulants, related aspects. Learning objectives Learning objectives Clot retraction Clot retraction Fibrinolysis Fibrinolysis Thromboses,
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Platelets (Thrombocytes)
Rafi Ahmed, MD Hematology Oncology Fellow
These factors prevent blood clotting - in normal state.
General Principles of Hemostasis Kristine Krafts, M.D.
Bleeding disorders Dr. Feras FARARJEH.
Drugs Used in Coagulation Disorders
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
HEMOSTASIS BY: SATHISH RAJAMANI. ASSOCIATE PROFESSOR.
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Coagulation Cascade of the Newborn
Steps in clotting mechanism
Activated Partial Thromboplastin Time (aPTT)
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding disorders Dr. Feras FARARJEH.
General Principles of Hemostasis Kristine Krafts, M.D.
Principles of Coagulation Screening II
Hemostasis Hemostasis depends on the integrity of Blood vessels
Hemostasis and Coagulation
Presentation transcript:

Coagulation Bruno Sopko

Content Biochemistry of haemocoagulation Laboratory test

Bleeding acid acid - - - + + + Vein injury + - + + Endotel platelet thrombus - Exposure of procoagulation phospholipids (df3) coagulation cascade fibrin net - thrombin Vasoconstriction in the injury site - + adrenalin + serotonin + Bleeding Vein injury myocytes and fibroblasts PDGF ADP + prostacyclin PGI2 - membr. phospholipids Arachidonic acid endoperoxides PGG2 PGH2 Collagen exposure von Wilebrand’s factor exposure endothelial descvamation Platelets adhesion thromboxane A2 + Arachidonic acid endoperoxides PGG2 PGH2 membr. phospholipids Platelet aggregation PAF Granulocytes, bazophils, macrophágs + von Wilebrand factor Endotel

Coagulation factors

Regulatory proteins

Classic-test tube coagulation cascade

Coagulation cascade in vivo

Formation of fibrin clot

Formation of fibrin clot

Effect of Warfarin Warfarin Warfarin

Thrombin roles

Physiologic anticoagulants

Fibrinolysis Clotting Cascade Fibrin degradation products Fibrinogen Fibrin-clot Plasminogen Plasmin T-PA F XIIa HMWK Kallikrein Urokinase Streptokinase

Laboratory methods Thrombocytes count Bleeding time (Duke) Prothrombine time (Quick’s test) aPTT Thrombin time

Thrombocytes count 200 – 400 x 103/µL (109/L) = 200 000 – 400 000 /µL Low risk of spontaneous bleeding, in case of thrombocytes count > 30 000 /µL (endothelium and plasma coagulation system being intact)

Bleeding time Ivy method: is the traditional format for this test. In the Ivy method, a blood pressure cuff is placed on the upper arm and inflated. A lancet or scalpel blade is used to make a stab wound on the underside of the forearm. The time from when the stab wound is made until all bleeding has stopped is measured and is called the bleeding time. Every 30 seconds, filter paper or a paper towel is used to draw off the blood. The test is finished when bleeding has stopped completely. Template method: a template is placed over the area to be stabbed and two incisions are made in the forearm using the template as a location guide. Duke method: a nick is made in an ear lobe or a fingertip is pricked to cause bleeding. A normal bleeding time for the Ivy method is less than five minutes from the time of the stab, 3 minutes for Duke method

Protrombin Time (Quick’s test) Prothrombin Time (PT) Plasma + Calcium + Tissue Thromboplastin TF + VIIa → Xa + V → IIa → CLOT PT only elevated Factor VII deficiency Congenital (very rare) Acquired (Vit K deficiency, liver disease) Factor VII inhibitor Rarely in pts with modest decreases of factor V or X

aPTT Activated Partial Thromboplastin Time (aPTT) aPTT only elevated Plasma + Calcium + Kaolin + Phospholipids Contact → XIa → IXa + VIII →Xa + Va →IIa →CLOT aPTT only elevated Factor XI, IX, or VIII deficiency Factor XI, IX, or VIII specific factor inhibitor Heparin contamination Antiphospholipid antibodies

Both PT-INR and aPTT are elevated Factor(s) X, V, or II deficiency Factor(s) X, V, or II inhibitor Improper anticoagulation ratio (Hct >60 or <15) High doses of heparin (↑ aPTT > ↑ PT-INR) Large Warfarin effect ((↑ PT-INR > ↑ aPTT) Low fibrinogen (<80 mg/dl)

Thrombin Clotting Time (TCT) Add thrombin to patient’s plasma This should directly clot fibrinogen Elevated in Heparin use DIC Dysfibrinogenemia Low fibrinogen levels High fibrinogen levels Uremia

Marks´ Basic Medical Biochemistry, A Clinical Approach, third edition, 2009 (M. Lieberman, A.D. Marks) Color Atlas of Biochemistry (J. Koolman, K.H. Roehm) Stanislav Matoušek:Patofyziologie koagulace, Thomas A. Whitehill: Coagulation Made Simple